Synapse - Marinela Capanu

Search Within

Marinela Capanu

Results (394)

Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)

Meeting Abstract

Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)

Meeting Abstract

Duffy, A.; Capanu, M.; Abou-Alfa, G. K.; Huitzel, D.; Williams, P.; Jarnagin, W.; Fong, Y.; Kelsen, D. P.; O'Reilly, E. M.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy

Meeting Abstract

Asmis, T. R.; Templeton, M.; Trocola, R.; Pincus, N.; Randazzo, J.; Marinela, C.; Kelsen, D. P.; Shah, M. A.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Molecular markers associated with response and clinical outcome to cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer (BOND2)

Meeting Abstract

Azuma, M.; Yang, D.; Carpanu, M.; Hollywood, E.; Lue-Yat, M.; Zhang, W.; Danenberg, K. D.; Danenberg, P. V.; Saltz, L.; Lenz, H.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy

Journal Article

Lassmann, S.; Tang, L.; Capanu, M.; Brabletz, T.; Schöpflin, A.; Zur Hausen, A.; Gonen, M.; Kemeny, N.; Shia, J.; Klimstra, D.; more...
Gastroenterology (2007)

Fulltext@MSK | Save

Reproductive history and risk of second primary breast cancer: The WECARE study

Journal Article

Largent, J. A.; Capanu, M.; Bernstein, L.; Langholz, B.; Mellemkjaer, L.; Malone, K. E.; Begg, C. B.; Haile, R. W.; Lynch, C. F.; Anton-Culver, H.; more...
Cancer Epidemiology Biomarkers and Prevention (2007)

Fulltext@MSK | Save

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis

Journal Article

Gallagher, D. J.; Capanu, M.; Raggio, G.; Kemeny, N.
Annals of Oncology (2007)

Fulltext@MSK | Save

Systemic chemotherapy does not increase the risk of gastrointestinal perforation

Journal Article

Asmis, T. R.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
Annals of Oncology (2007)

Fulltext@MSK | Save

Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)

Meeting Abstract

Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase II trial of preoperative cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy: PET scan after induction therapy may identify early treatment failure

Meeting Abstract

Ilson, D. H.; Bains, M.; Rizk, N.; Shah, M.; Rusch, V.; Capanu, M.; Flores, R.; Kelsen, D.; Park, B.; Kepler, S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save